Changsheng Ye

机构：Hejian People's Hospital, East China University of Technology, Third People's Hospital of Huzhou · ORCID：0000-0002-1978-0794

发表论文 84 篇 · 总被引 1311 次 · h-index 21

代表论文

• Pyrotinib versus placebo in combination with trastuzumab and docetaxel as first line treatment in patients with HER2 positive metastatic breast cancer (PHILA): randomised, double blind, multicentre, phase 3 trial (2023 · BMJ · 被引 87)
• Safety, Efficacy, and Pharmacokinetics of SHR-A1811, a Human Epidermal Growth Factor Receptor 2–Directed Antibody-Drug Conjugate, in Human Epidermal Growth Factor Receptor 2–Expressing or Mutated Advanced Solid Tumors: A Global Phase I Trial (2024 · Journal of Clinical Oncology · 被引 47)
• Propofol Versus Remimazolam on Cognitive Function, Hemodynamics, and Oxygenation During One-Lung Ventilation in Older Patients Undergoing Pulmonary Lobectomy: A Randomized Controlled Trial (2023 · Journal of Cardiothoracic and Vascular Anesthesia · 被引 44)
• A randomized, multicenter phase III Study of once-per-cycle administration of efbemalenograstim alfa (F-627), a novel long-acting rhG-CSF, for prophylaxis of chemotherapy-induced neutropenia in patients with breast cancer (2024 · BMC Cancer · 被引 18)
• Fuzuloparib with or without apatinib in patients with HER2-negative metastatic breast cancer with germline BRCA1/2 mutations (FABULOUS): interim analysis of a multicentre, three-arm, open-label, randomised, phase 3 trial (2025 · The Lancet Oncology · 被引 8)
• Aeolian activities change and possible mechanisms in central Asia on sub-orbital to decadal timescales (2023 · Quaternary International · 被引 8)